Shanghai, China

Qiu Jin

This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Shanghai Zhimeng Biopharma, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Qiu Jin. Retrieved from https://idiyas.com/inventor/qiu-jin-bkzmepsy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 6.2

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Qiu Jin: Innovator in Neuroprotective Compounds

Introduction

Qiu Jin is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of neuroprotection through his innovative research and development. His work focuses on compounds that offer neuroprotective effects, which are crucial for advancing medical treatments.

Latest Patents

Qiu Jin holds a patent for a compound having a neuroprotective effect, along with its preparation method and uses. The patent details a compound with a specific structure, as described in the documentation. This compound is designed to provide neuroprotection, showcasing Qiu Jin's commitment to addressing critical health challenges.

Career Highlights

Qiu Jin is associated with Shanghai Zhimeng Biopharma, Inc., where he applies his expertise in biopharmaceuticals. His role at the company allows him to contribute to the development of innovative solutions in the healthcare sector. His dedication to research and development has positioned him as a key figure in his field.

Collaborations

Some of Qiu Jin's notable coworkers include Bo Liang and Huanming Chen. Their collaboration fosters a dynamic environment for innovation and research, enhancing the potential for groundbreaking discoveries in neuroprotection.

Conclusion

Qiu Jin's work in developing neuroprotective compounds represents a significant advancement in medical science. His contributions are vital for future research and therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…